- Home
- A-Z Publications
- Current Computer - Aided Drug Design
- Previous Issues
- Volume 3, Issue 2, 2007
Current Computer - Aided Drug Design - Volume 3, Issue 2, 2007
Volume 3, Issue 2, 2007
-
-
Editorial [Hot Topic: Anti-Viral Agents and Emerging Diseases: Part - I (Guest Editor: Supa Hannongbua)]
More LessThe drug discovery research for new potent anti-viral drugs is one of the most interesting areas that may adopt a long process ranging from screening to marketing. Several attempts have been made in this direction because of the viral infection such as HIV, dengue and particular emerging diseases such as SARS and avian influenza. However, the severe problems are faced due to the mutation of DNA as well as R Read More
-
-
-
Structural Aspects of Non-Nucleoside HIV-1 Reverse Transcriptase Inhibition
Authors: Anton Beyer, Luckhana Lawtrakul, Pornpan Pungpo and Peter WolschannHIV-1 Reverse transcriptase (RT) is an essential enzyme for HIV-1 replication and, therefore, it is an important target for the attack of antiviral agents. Although some products are already on the market, there is need to design new drugs, because mutation in drug interacting disease proteins decreases the efficiency of the existing drugs. Non-nucleoside RT inhibitors fill up an allosteric, mainly hydrophobic pocket in a d Read More
-
-
-
A Search for Vaccines and Therapeutic for Dengue: A Review
Authors: Habibah A. Wahab, Rohana Yusof and Noorsaadah A. RahmanDengue is a serious emerging or re-emerging infectious disease that is endemic in over 100 countries. There has been an estimated of 50 million infection per year globally with more than 2.5 billion people are at risk for epidemic transmission. The major burden for dengue is in the south-east Asia and the western Pacific although there have been increasing reports of this disease in the Americas. This infectious disease is cause Read More
-
-
-
Structural Information and Computational Methods Used in Design of Neuraminidase Inhibitors
Authors: Chak Sangma and Supa HannongbuaIt will take only a few years, even with constant surveillance, before the avian influenza subtype H5N1 virus has spread around the world. The main agents that can use to fight the coming outbreak, while vaccines are not yet available and only useful in prevention, are anti-neuraminidase drugs. Only two approved drugs are available and supplies are inadequate for everyone. Even worse is the likelihood that drug resistance strain Read More
-
-
-
Computer-Aided Drug Design: Integration of Structure-Based and Ligand-Based Approaches in Drug Design
Authors: Philip Prathipati, Anshuman Dixit and Anil K. SaxenaIn silico high throughput screens provide an efficient (time and money) and effective (with comparable or better accuracy) alternatives in comparison to their experimental counterparts, and hence is of enormous interest to drug discovery research. However the assessment of a variety of virtual screening techniques ranging from simple fingerprint based similarity searching to the sophisticated docking algorithm Read More
-
-
-
Hybrid Usage of Computational Tools in Drug Synthesis
Authors: Canan Atilgan and Viktorya AviyenteWe describe several computational methodologies used in aiding the chemical synthesis of drugs. We first summarize quantum mechanical approaches that weigh thermodynamical and kinetic factors in selecting the possible pathways during synthesis. The two major problems encountered in computational approaches are the efficient sampling of the conformational space and the incorporation of solvent effect Read More
-
Volumes & issues
-
Volume 21 (2025)
-
Volume 20 (2024)
-
Volume 19 (2023)
-
Volume 18 (2022)
-
Volume 17 (2021)
-
Volume 16 (2020)
-
Volume 15 (2019)
-
Volume 14 (2018)
-
Volume 13 (2017)
-
Volume 12 (2016)
-
Volume 11 (2015)
-
Volume 10 (2014)
-
Volume 9 (2013)
-
Volume 8 (2012)
-
Volume 7 (2011)
-
Volume 6 (2010)
-
Volume 5 (2009)
-
Volume 4 (2008)
-
Volume 3 (2007)
-
Volume 2 (2006)
-
Volume 1 (2005)
Most Read This Month
Article
content/journals/cad
Journal
10
5
false
en
